Does Dr. FELIX MENDOZA ROSA have financial conflicts of interest?

Dr. FELIX MENDOZA ROSA (M.D.) has received a total of $2,422 in pharmaceutical and medical device industry funding between 2021 and 2025. This includes $2,422 in personal promotional payouts (consulting, meals, travel) and $0 in clinical research grants. Financial ties do not automatically imply conflict of interest, but are disclosed under the Sunshine Act.

Which pharmaceutical companies pay Dr. FELIX MENDOZA ROSA?

According to CMS Open Payments data, Dr. FELIX MENDOZA ROSA received funding from PROCEPT BIOROBOTICS CORPORATION ($1,616), BOSTON SCIENTIFIC CORPORATION ($674), and CALLIDITAS THERAPEUTICS US ($132).

Does Dr. FELIX MENDOZA ROSA receive research grants or speaking fees?

Dr. FELIX MENDOZA ROSA has received $2,422 in general promotional payments (such as consulting honoraria, meals, and speaking fees) and $0 in clinical research grants.

DR. FELIX MENDOZA ROSA

M.D.Real-Time Hydrated

Specialty: Urology

Practice Location: CAYEY, PR 00736

NPI Number: 1558339515

LIFETIME INDUSTRY VALUE

$2,422

2021 – 2025 Cumulative

Conflict of Interest Analysis

Dr. MENDOZA ROSA is a verified Urology practitioner based in CAYEY, PR.

Between 2021 and 2025, Dr. MENDOZA ROSA had an overall industry promotional and research financial footprint of $2,422 as recorded in the federal CMS Open Payments database.

$2,422 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
$0 was allocated to sponsored clinical trials and medical research activities.

Dr. MENDOZA ROSA's primary funding source is PROCEPT BIOROBOTICS CORPORATION, which accounts for $1,616 (representing 66.7% of overall industry footprint).

Data coverage: 2021 – 2025 · Source: CMS Open Payments · CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments

Research Funding

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

PROCEPT BIOROBOTICS CORPORATION

Rank 1

$1,616

66.7%

BOSTON SCIENTIFIC CORPORATION

Rank 2

$674

27.8%

CALLIDITAS THERAPEUTICS US

Rank 3

$132

5.5%

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:

2025

Filter < $250

Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.